KROS
KerosยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
KROS Profile
Keros Therapeutics, Inc.
A clinical-stage biopharmaceutical company that developing products for hematological and musculoskeletal disorders
1050 Waltham Street, Suite 302 02421, Lexington, Massachusetts
--
Keros Therapeutics, Inc., was originally incorporated under the laws of the State of Delaware in December 2015. The company is a clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for patients with hematological and musculoskeletal diseases. The company is a leader in understanding the role of transforming growth factor-beta (a family of proteins), a major regulator of red blood cell and platelet production and muscle and bone growth, repair and maintenance.
